Medicine and Dentistry
Blood Donor
91%
Donor
65%
Infection
61%
Severe Acute Respiratory Syndrome Coronavirus 2
50%
Antibody
34%
Adverse Event
25%
Female
23%
Hepatitis E Virus
22%
Seroprevalence
19%
Patient
19%
Prevalence
18%
Cohort Analysis
18%
Alertness
16%
Mortality Rate
16%
Virus Infection
16%
RNA
16%
Pneumonia
16%
Blood Group ABO System
16%
Reinfection
16%
Immunocompromised Patient
16%
Hepatitis E
16%
Adult
16%
Blood Group O
16%
Cohort Effect
16%
Nucleic Acid
16%
Lochia
16%
Ferritin
16%
Iron
16%
Bleeding
16%
Signal Transduction
16%
Myometrium
16%
Pregnancy
16%
Supplementation
16%
Progesterone
16%
Migraine
16%
Pericarditis
16%
Placebo
16%
Evaluation Study
16%
Odds Ratio
15%
Homelessness
14%
Hemoglobin
14%
Male
13%
Follow up
12%
Comprehension
12%
Satisfaction
12%
COVID-19
10%
Polymerase Chain Reaction
9%
Physician
8%
Genetic Correlation
8%
Health
8%
Immunology and Microbiology
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Monospecific Antibody
44%
COVID-19
37%
Hepatitis E Virus
29%
Viral Disease
22%
Hepatitis E
20%
Neutralization
19%
Prevalence
18%
Blood Plasma
18%
Time
16%
Mortality Rate
16%
Antibody Screening
16%
Infliximab
16%
Azathioprine
16%
ABO Blood Group System
16%
Blood Group O
16%
Inflammatory Bowel Disease
16%
Immunocompromised Patient
16%
Neutralizing Antibody
16%
Pharmacokinetics
16%
Pericarditis
16%
Omicron Coronavirus Variant
16%
Seroprevalence
11%
Immunoglobulin M
9%
Antigenicity
5%